Eosinophil granule proteins are selective activators of human heart mast cells

V Patella1, G de Crescenzo, I Marino

  • 1Division of Clinical Immunology and Allergy, University of Naples Federico II, Italy.

Insights

Eosinophil cationic proteins, like ECP and MBP, activate human cardiac mast cells, releasing histamine and tryptase. This finding helps explain cardiac damage in eosinophilia patients.

Area of Science:

  • Immunology
  • Cardiology
  • Cell Biology

Background:

  • Eosinophilia involves eosinophil infiltration and cardiac deposition of granule proteins.
  • Eosinophil granule proteins contribute to cardiac disease in some eosinophilia cases.

Purpose of the Study:

  • To investigate the in vitro effects of four key eosinophil granule proteins on human cardiac mast cells.
  • To determine which eosinophil proteins activate mast cells and mediate histamine and tryptase release.

Main Methods:

  • Isolated human cardiac mast cells (HHMC) were exposed to eosinophil cationic protein (ECP), major basic protein (MBP), eosinophil-derived neurotoxin (EDN), and eosinophil peroxidase (EPO).
  • Histamine and tryptase release were measured following protein exposure.
  • Experiments included calcium and temperature dependency studies, antibody neutralization, and metabolic inhibition.

Main Results:

  • ECP and MBP significantly stimulated histamine and tryptase release from HHMC.
  • EDN and EPO did not induce mast cell activation.
  • The ECP/MBP-induced activation was dependent on calcium, temperature, and cellular metabolism, and was blocked by specific antibodies.

Conclusions:

  • ECP and MBP are selective activators of human cardiac mast cells.
  • These activated mast cells contribute to cardiac pathology observed in patients with eosinophilia.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...